1-12 of 12
Rebecca Klisovic
Close
Sort by
Journal Articles

Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

Maria Teresa Voso, Richard A. Larson, MD, Thomas Prior, Guido Marcucci, Dan Jones, MD PhD, Jürgen Krauter, MD, Michael Heuser, MD, Serena Lavorgna, PhD, Josep Nomdedeu, MD PhD, Susan M. Geyer, PhD, Rebecca Klisovic, MD, Andrew H Wei, MBBS, PhD, Jorge Sierra, MD, Miguel A. Sanz, MD, Joseph M. Brandwein, MD FRCPC, Theo M de Witte, MD, Joop H. Jansen, Dietger Niederweiser, Frederick R. Appelbaum, MD, Bruno C. Medeiros, MD, Martin S. Tallman, MD, Richard F. Schlenk, MD, Arnold Ganser, MD, Sergio Amadori, MD, Yuan Cheng, PhD, Insa Gathmann, Eva Tiecke, PhD, Christian Thiede, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard M. Stone, MD, Clara D. Bloomfield, MD, Francesco Lo-Coco, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2668.
https://doi.org/10.1182/blood-2018-99-114318
Published: 2018
Journal Articles

Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Kristen Marie O'Dwyer, MD, Brent Wood, MDPhD, Min Fang, MDPhD, Matthew J. Wieduwilt, MD PhD, Ibrahim Aldoss, MD, Jae H. Park, MD, Rebecca Klisovic, MD, Maria R. Baer, MD, Wendy Stock, MD, Rupali Bhave, MD, Megan Othus, PhD, Mark R. Litzow, MD, Richard M. Stone, MD, Harry P. Erba, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 33.
https://doi.org/10.1182/blood-2018-99-111992
Published: 2018
Journal Articles

Response Rates, Non-Relapse Mortality, and Financial Implications of Transplant-Associated Thrombotic Microangiopathy Treated with Eculizumab

John L Vaughn, MD, Qiuhong Zhao, MS, Parvathi Ranganathan, PhD, Patrick Elder, Basem M. William, MRCP,MD, Marcin Puto, PharmD, Julianna Roddy, PharmD, Rebecca Klisovic, William Blum, MD, Don M Benson, Jr., MD PhD, Samantha M. Jaglowski, MDMPH, Alice S. Mims, MD MSCR, Jonathan E. Brammer, MD, Bhavana Bhatnagar, DO, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH, Leslie A Andritsos, MD, Sam Penza, MD, Allison R. Walker, MD MPH, Steven M. Devine, MD, Spero R Cataland, MD, Sumithira Vasu, MDMBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1932.
https://doi.org/10.1182/blood.V130.Suppl_1.1932.1932
Published: 2017
Journal Articles

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

Brief Report
Parvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, Jessica Hofstetter, Alison Walker, Katherine Walsh, Bhavana Bhatnagar, Rebecca Klisovic, Sumithira Vasu, Mitch A. Phelps, Steven Devine, Sharon Shacham, Michael Kauffman, Guido Marcucci, William Blum, Ramiro Garzon
Journal: Blood
Blood (2015) 125 (17): 2689–2692.
https://doi.org/10.1182/blood-2014-10-607648
Published: 2015
Includes: Supplemental data
Journal Articles

Phase I Study Of The Combination Of Midostaurin, Bortezomib and Chemotherapy In Relapsed/Refractory Acute Myeloid Leukemia (AML): Targeting Aberrant Tyrosine Kinase Activity

Alison R Walker, MD, Hongyan Wang, PhD, Rebecca Klisovic, MD, Katherine Walsh, MD, Sumithira Vasu, MBBS, Ramiro Garzon, MD, Steven M. Devine, MD, Amy Drake, William Blum, MD, Guido Marcucci, MD
Journal: Blood
Blood (2013) 122 (21): 3966.
https://doi.org/10.1182/blood.V122.21.3966.3966
Published: 2013
Journal Articles

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

Pearlly Yan, David Frankhouser, Mark Murphy, Hok-Hei Tam, Benjamin Rodriguez, John Curfman, Michael Trimarchi, Susan Geyer, Yue-Zhong Wu, Susan P. Whitman, Klaus Metzeler, Alison Walker, Rebecca Klisovic, Samson Jacob, Michael R. Grever, John C. Byrd, Clara D. Bloomfield, Ramiro Garzon, William Blum, Michael A. Caligiuri, Ralf Bundschuh, Guido Marcucci
Journal: Blood
Blood (2012) 120 (12): 2466–2474.
https://doi.org/10.1182/blood-2012-05-429175
Published: 2012
Includes: Supplemental data
Journal Articles

Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia

Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham, Michael Kauffman, Alison Walker, Rebecca Klisovic, William Blum, Michael Caligiuri, Carlo M. Croce, Guido Marcucci, Ramiro Garzon
Journal: Blood
Blood (2012) 120 (9): 1765–1773.
https://doi.org/10.1182/blood-2012-04-423160
Published: 2012
Journal Articles

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

Clinical Trials & Observations
William Blum, Sebastian Schwind, Somayeh S. Tarighat, Susan Geyer, Ann-Kathrin Eisfeld, Susan Whitman, Alison Walker, Rebecca Klisovic, John C. Byrd, Ramasamy Santhanam, Hongyan Wang, John P. Curfman, Steven M. Devine, Samson Jacob, Celia Garr, Cheryl Kefauver, Danilo Perrotti, Kenneth K. Chan, Clara D. Bloomfield, Michael A. Caligiuri, Michael R. Grever, Ramiro Garzon, Guido Marcucci
Journal: Blood
Blood (2012) 119 (25): 6025–6031.
https://doi.org/10.1182/blood-2012-03-413898
Published: 2012
Includes: Supplemental data
Journal Articles

RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia

Josephine Aimiuwu, Hongyan Wang, Ping Chen, Zhiliang Xie, Jiang Wang, Shujun Liu, Rebecca Klisovic, Alice Mims, William Blum, Guido Marcucci, Kenneth K. Chan
Journal: Blood
Blood (2012) 119 (22): 5229–5238.
https://doi.org/10.1182/blood-2011-11-382226
Published: 2012
Includes: Supplemental data
Journal Articles

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)

William Blum, MD, Rebecca Klisovic, MD, Shujun Liu, PhD, Ramiro Garzon, MD, Cheryl Kefauver, RN, Zhongfa Liu, PhD, Jon Mickle, CNP, Hollie Devine, CNP, Steve Devine, MD, Michael R Grever, MD, Kenneth K Chan, PhD, Miguel Villalona-Calero, MD, John C. Byrd, MD, Guido Marcucci, MD
Journal: Blood
Blood (2008) 112 (11): 2957.
https://doi.org/10.1182/blood.V112.11.2957.2957
Published: 2008
Journal Articles

High Rates of Early Donor Chimerism and Low Risk of Chronic GVHD Can Be Achieved in Poor Risk Patients Undergoing Unrelated Donor Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen Incorporating Fludarabine, Busulfan, and Rabbit ATG.

Mehdi Hamadani, MD, Patrick Elder, Farrukh Awan, David Krugh, William Blum, MD, Thomas Lin, MD, PhD, Leslie Andritsos, MD, Thomas Bechtel, Kristie Blum, MD, Rebecca Klisovic, MD, Steven M. Devine, MD
Journal: Blood
Blood (2007) 110 (11): 5080.
https://doi.org/10.1182/blood.V110.11.5080.5080
Published: 2007
Journal Articles

Imatinib Mesylate-Induced Complete Cytogenetic Response in Acute Myeloid Leukemia with t(5;12)(q33;p13).

William Blum, MD, Guido Marcucci, MD, Hollie Devine, CNP, Rebecca Klisovic, MD
Journal: Blood
Blood (2006) 108 (11): 4414.
https://doi.org/10.1182/blood.V108.11.4414.4414
Published: 2006